In piglet nursery operations, Sanhuang Likang Powder is handled as a dry veterinary API for subsequent dilution into medicated feed premixes. The material is first screened through a 900 µm conical sieve to remove agglomerates and then preblended with lactose monohydrate or wheat middlings at a 1:5 intermediate ratio in a 200 L drum blender. This preblend is transferred to a 2,000 kg horizontal ribbon mixer with a 1:1.5 length-to-diameter ratio, where it is further diluted to a working premix strength of 0.5–5.0% w/w depending on the target finished feed dose. Paddle-tip speed is maintained below 4 m/s to limit shear-induced build-up of resinous extract particles on the mixer wall. Homogeneity is assessed by sampling 10 locations and quantifying a marker alkaloid; a coefficient of variation below 5.0% is the acceptance limit under EU Regulation 2019/4 for medicated feed. The finished premix is packaged in multi-wall paper sacks with an inner polyethylene liner at a moisture content below 8.0% and a water activity below 0.60. The terminal dosage form is a dry premix for on-farm mixing into prestarter rations. The batch record must document cleanout following 21 CFR 225.65, and residual carryover is checked after each production campaign to prevent cross-contamination of non-target animal feeds. A site-specific validation batch is required because published data for this specific powder configuration in piglet feeds is limited.

Poultry drinking water solution clarity depends on hardness buffering and carrier salt selection

Commercial broiler and layer production facilities convert Sanhuang Likang Powder into water-soluble powder or concentrated oral solution for proportioner dosing. The API contains polyphenolic glycosides and polysaccharides that exhibit pH-dependent precipitation; hard water with bicarbonate alkalinity above 250 mg/L as CaCO₃ causes immediate clouding and settling in header tanks. A dry carrier composed of anhydrous citric acid at 0.5–1.0% w/w and anhydrous sodium sulfate at 10–20% w/w relative to API mass is preblended in a low-shear ribbon mixer before final dilution with glucose monohydrate. The solution concentrate is prepared by dispersing the powder in deionized water at 25–30°C, adjusting to pH 6.5–7.5 with sodium citrate, and passing through a 100 µm inline strainer before bottling. Microbiology of the non-sterile powder is controlled to Ph. Eur. 5.1.4 limits for total aerobic microbial count below 10⁴ CFU/g and total yeast and mould count below 10² CFU/g. The terminal finished product is either a sachet of water-soluble powder or a 1 L polyethylene concentrate bottle, both intended for metered dilution into drinking water lines. In hard water regions, an inline acidifier must be used upstream of the proportioner to prevent precipitate formation in nipple drinkers; otherwise flock-level water intake can drop by more than 10% within 48 h of treatment. Residual solvent control follows VICH GL18 because carrier preblending may involve granulation auxiliaries that leave trace ethanol or isopropyl alcohol.

Ruminant Injectable Solutions, Sterile Filtration, and Pyrogen Control

Parenteral preparations based on Sanhuang Likang Powder require a fully aqueous extraction process because direct dispersion of the crude powder in Water for Injection produces particles above 10 µm that are not removable by terminal sterilisation filtration. The API is extracted in WFI at 60°C for 45–60 min, clarified through a 0.45 µm polyethersulfone membrane, and then sterile-filtered through a 0.22 µm polyvinylidene fluoride capsule at a differential pressure below 1.5 bar. The final extract solids content is adjusted to 5–20 mg/mL, pH is maintained at 6.8–7.2 with 0.1 M sodium hydroxide, and the solution is filled under ISO 14644-1 Class 7 laminar flow. Terminal autoclaving is avoided because flavonoid glycosides degrade and darken at 121°C; the chosen sterilisation route is aseptic filtration in compliance with Ph. Eur. 5.1.1. Bacterial endotoxins are controlled below 0.5 EU/mg by testing each batch according to Ph. Eur. 2.6.14. The terminal product is a 50 mL or 100 mL amber Type I glass vial for intramuscular injection in cattle and sheep. Process hold time between filtration and filling is kept below 4 h because extract colloids re-aggregate in aqueous solution and increase turbidity, which can reduce filter capacity and cause sterile-filter membrane fouling. Published batch-scale sterilising-grade filter capacity data for this specific multi-herb extract is limited; filter sizing is therefore confirmed by a small-scale Vmax trial before each production campaign.

Why Does Wet Granulation Produce Low-Yield Tablets From Multi-Herb Extract Powders?

Wet granulation of Sanhuang Likang Powder for companion animal tablets is problematic because the dried extract contains hygroscopic sugars and pectin-like carbohydrates that form hard lumps when exposed to aqueous binder at product temperatures above 30°C. A dry granulation route using a roll compactor with 25 mm diameter rollers and 0.8–1.2 mm screen granulation is preferred. The dry binder system comprises microcrystalline cellulose type 102 at 15–25% w/w, dibasic calcium phosphate dihydrate at 10–20% w/w, crospovidone at 2–4% w/w, and sodium stearyl fumarate at 1.0–1.5% w/w. The API is adjusted to 100 mg or 200 mg per tablet. Compression is performed on a 27-station rotary press with a main compression force of 8–14 kN and a pre-compression force of 2–4 kN. Tablet hardness is targeted at 60–120 N, friability below 1.0% per Ph. Eur. 2.9.7, and disintegration below 15 min in water at 37°C per USP 701. The terminal finished product is a film-coated oval tablet for oral administration to dogs and cats. Film coating with an immediate-release hydroxypropyl methylcellulose system at 2–3% weight gain is conducted at an inlet air temperature below 60°C to avoid extract darkening. Process yield falls below 85% if roll compaction pressure is not matched to API particle size distribution, because the extract fractures into fines that cause capping.

For hard capsule filling of Sanhuang Likang Powder, direct blending is limited by the cohesive nature of the spray-dried extract, which typically shows a Hausner ratio above 1.35 when tested according to USP 1174. To achieve acceptable flow on an automatic capsule filler, the API is first milled through a 600 µm screen and then blended with 0.25–0.5% w/w colloidal silicon dioxide and 0.5% w/w magnesium stearate in a diffusion mixer at 10–15 rpm for 15–20 min. The blend is filled into hydroxypropyl methylcellulose capsules of size 0 or size 1 at a target fill weight of 250–400 mg. Fill weight uniformity is checked every 15 min on 20 capsules, with acceptance limits of ±5% relative to the mean according to USP 2091 or the supplier’s qualified in-process procedure. The terminal dosage form is an immediate-release capsule for companion animal gastrointestinal disorders. Storage stability requires a desiccant canister when the capsule is packed in high-density polyethylene bottles, because the extract softens at relative humidity above 60%. The finished product is released under Ph. Eur. 5.1.4 microbial limits for oral solid dosage forms, with a total aerobic microbial count below 10³ CFU/g and absence of Escherichia coli per 1 g. Powder bed stratification during capsule filling is a known failure mode; regular verification of blend uniformity by sampling 10 points across the hopper is required after every 30 min of continuous operation.

When Sanhuang Likang Powder Is Layered onto Granules for Oral Drench Administration in Ruminants

Granule manufacturing from Sanhuang Likang Powder for oral drench or top-dressing in calves and lambs is carried out in a fluidised bed dryer with a top-spray insert. The process builds the API onto a sugar sphere substrate of 500–710 µm using a binder solution of povidone K30 at 3–5% w/w in a 50:50 water–isopropyl alcohol mixture. Spray rate is set between 20–40 g/min per kg of substrate, and inlet air temperature is held at 45–55°C to maintain product temperature below 40°C. The API is suspended rather than dissolved in the binder, so continuous agitation in the spray reservoir is required to prevent sedimentation and nozzle clogging. After layering, the granules are dried to a loss-on-drying value below 3.0% and screened through 1.0 mm and 0.5 mm sieves to remove fines and oversized particles. The terminal product is a granular oral formulation packed in aluminium foil sachets of 50 g or 100 g, to be mixed into milk replacer or sprinkled onto starter feed. Microbiological quality follows Ph. Eur. 5.1.4; residual isopropyl alcohol is controlled under VICH GL18 with a limit not exceeding 50 ppm in the dried granule. If inlet air humidity exceeds 60% RH, the extract powder absorbs moisture during the layering process, causing agglomeration and processor yield loss below 70%, so the fluidised bed is operated with a dehumidified air supply of 10–15% RH.